A detailed history of Ubs Group Ag transactions in Opti Nose, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 441 shares of OPTN stock, worth $185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
441
Previous 1,598 72.4%
Holding current value
$185
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.67 - $1.27 $775 - $1,469
-1,157 Reduced 72.4%
441 $0
Q2 2024

Aug 13, 2024

SELL
$0.82 - $1.44 $58,747 - $103,165
-71,643 Reduced 97.82%
1,598 $1,000
Q1 2024

May 13, 2024

SELL
$1.17 - $1.94 $5,706 - $9,461
-4,877 Reduced 6.24%
73,241 $106,000
Q4 2023

Feb 09, 2024

BUY
$1.02 - $1.47 $39,924 - $57,538
39,142 Added 100.43%
78,118 $100,000
Q3 2023

Nov 09, 2023

SELL
$0.93 - $1.38 $6,041 - $8,964
-6,496 Reduced 14.29%
38,976 $47,000
Q2 2023

Aug 11, 2023

BUY
$1.11 - $2.05 $48,152 - $88,931
43,381 Added 2074.65%
45,472 $55,000
Q1 2023

May 12, 2023

SELL
$1.63 - $2.02 $1,633 - $2,024
-1,002 Reduced 32.4%
2,091 $4,000
Q4 2022

Feb 08, 2023

SELL
$1.68 - $3.7 $4,828 - $10,633
-2,874 Reduced 48.16%
3,093 $5,000
Q3 2022

Nov 10, 2022

BUY
$3.43 - $4.01 $16,018 - $18,726
4,670 Added 360.06%
5,967 $22,000
Q2 2022

Aug 10, 2022

SELL
$1.76 - $3.82 $11,684 - $25,360
-6,639 Reduced 83.66%
1,297 $5,000
Q1 2022

May 16, 2022

SELL
$1.77 - $2.93 $10,851 - $17,963
-6,131 Reduced 43.58%
7,936 $20,000
Q4 2021

Feb 14, 2022

BUY
$1.55 - $3.1 $21,803 - $43,607
14,067 New
14,067 $22,000
Q3 2021

Nov 15, 2021

SELL
$2.35 - $3.16 $10,835 - $14,570
-4,611 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$2.91 - $3.83 $2,886 - $3,799
-992 Reduced 17.7%
4,611 $14,000
Q1 2021

May 12, 2021

SELL
$3.47 - $4.75 $10,403 - $14,240
-2,998 Reduced 34.86%
5,603 $21,000
Q4 2020

Feb 11, 2021

BUY
$3.2 - $4.98 $27,523 - $42,832
8,601 New
8,601 $36,000
Q3 2020

Nov 12, 2020

SELL
$3.69 - $7.09 $18,461 - $35,471
-5,003 Closed
0 $0
Q2 2020

Jul 31, 2020

SELL
$3.58 - $7.44 $26,925 - $55,956
-7,521 Reduced 60.05%
5,003 $37,000
Q1 2020

May 01, 2020

SELL
$3.49 - $9.2 $58,841 - $155,112
-16,860 Reduced 57.38%
12,524 $56,000
Q4 2019

Feb 14, 2020

SELL
$6.27 - $11.41 $15,524 - $28,251
-2,476 Reduced 7.77%
29,384 $271,000
Q3 2019

Nov 14, 2019

BUY
$4.75 - $8.38 $57,650 - $101,708
12,137 Added 61.54%
31,860 $223,000
Q2 2019

Aug 14, 2019

BUY
$6.4 - $10.94 $57,254 - $97,869
8,946 Added 83.01%
19,723 $140,000
Q1 2019

May 14, 2019

BUY
$6.1 - $10.3 $23,790 - $40,170
3,900 Added 56.71%
10,777 $111,000
Q4 2018

Feb 14, 2019

SELL
$5.84 - $11.92 $12,176 - $24,853
-2,085 Reduced 23.26%
6,877 $43,000
Q3 2018

Nov 14, 2018

BUY
$12.43 - $29.76 $42,945 - $102,820
3,455 Added 62.74%
8,962 $111,000
Q2 2018

Aug 14, 2018

BUY
$18.75 - $28.46 $40,425 - $61,359
2,156 Added 64.34%
5,507 $154,000
Q1 2018

May 15, 2018

BUY
$15.91 - $20.82 $12,775 - $16,718
803 Added 31.51%
3,351 $67,000
Q4 2017

Feb 14, 2018

BUY
$15.2 - $20.76 $38,729 - $52,896
2,548
2,548 $48,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $35M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.